Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness

[1]  Benjamin L. Ebert.  Clonal Hematopoiesis , 2020, Definitions.

[2]  P. Lasko,et al.  Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster. , 2019, Neuro-oncology.

[3]  A. Tefferi,et al.  EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental , 2018, Blood Cancer Journal.

[4]  G. Sauvageau,et al.  H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations. , 2017, Blood.

[5]  A. Riccio,et al.  H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas. , 2017, Cancer cell.

[6]  M. Konopleva,et al.  Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia , 2017, International journal of molecular sciences.

[7]  Gary D Bader,et al.  Tracing the origins of relapse in acute myeloid leukaemia to stem cells , 2017, Nature.

[8]  R. McLendon,et al.  Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG , 2017, Molecular Cancer Research.

[9]  B. Porse,et al.  EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas , 2017, Nature Medicine.

[10]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[11]  W. Hiddemann,et al.  Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. , 2016, Blood.

[12]  Iannis Aifantis,et al.  Emerging concepts of epigenetic dysregulation in hematological malignancies , 2016, Nature Immunology.

[13]  R. Cummings,et al.  S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 , 2016, Proceedings of the National Academy of Sciences.

[14]  B. Garcia,et al.  Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape , 2016, Science.

[15]  H. Kestler,et al.  RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features , 2016, Leukemia.

[16]  Keith L. Ligon,et al.  Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma , 2016, Nature Communications.

[17]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[18]  B. Klein,et al.  EZH2 in normal hematopoiesis and hematological malignancies , 2015, Oncotarget.

[19]  A. Lennartsson,et al.  Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis. , 2015, Experimental hematology.

[20]  D. Neuberg,et al.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. , 2015, Blood.

[21]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[22]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[23]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[24]  A. Shilatifard,et al.  Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling , 2014, Science.

[25]  E. Laurenti,et al.  The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress , 2014, Nature.

[26]  Liliana Goumnerova,et al.  Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma , 2014, Nature Genetics.

[27]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[28]  Lincoln D. Stein,et al.  Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.

[29]  I. Weissman,et al.  Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.

[30]  Jian-Bing Fan,et al.  Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion. , 2014, Cell stem cell.

[31]  Stein Aerts,et al.  Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia , 2013, PLoS genetics.

[32]  David T. W. Jones,et al.  Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. , 2013, Cancer cell.

[33]  M. Stratton,et al.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone , 2013, Nature Genetics.

[34]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[35]  H. Kantarjian,et al.  Low frequency of H3.3 mutations and upregulated DAXX expression in MDS. , 2013, Blood.

[36]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[37]  I. Weissman,et al.  Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.

[38]  F. Prósper,et al.  Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics , 2012, PloS one.

[39]  David T. W. Jones,et al.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.

[40]  Ken Chen,et al.  Clonal architecture of secondary acute myeloid leukemia. , 2012, The New England journal of medicine.

[41]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[42]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[43]  Augustin Ferrant,et al.  Cytarabine dose for acute myeloid leukemia. , 2011, The New England journal of medicine.

[44]  D. Gilliland,et al.  Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms , 2010, Leukemia.

[45]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[46]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[47]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[48]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[49]  J. Dick,et al.  Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells , 2005, Leukemia.

[50]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[51]  Max Jan,et al.  Clonal hematopoiesis. , 2017, Seminars in hematology.

[52]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[53]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..